These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22300458)

  • 1. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
    Tseng CH
    BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes.
    Tseng CH
    Clin Genitourin Cancer; 2013 Dec; 11(4):508-14. PubMed ID: 23791436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.
    Tseng CH
    Metabolism; 2012 Jul; 61(7):1003-9. PubMed ID: 22237115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.
    Lind M; Fahlén M; Eliasson B; Odén A
    Prim Care Diabetes; 2012 Apr; 6(1):53-9. PubMed ID: 22056422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan.
    Tseng CH
    Acta Diabetol; 2013 Dec; 50(6):879-86. PubMed ID: 23508375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
    J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese.
    Tseng CH
    Eur J Clin Invest; 2013 Jun; 43(6):595-601. PubMed ID: 23550697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.
    Tseng CH; Chong CK; Tseng CP; Chan TT
    Ann Med; 2009; 41(5):371-9. PubMed ID: 19191082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
    Velicer CM; Dublin S; White E
    Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
    Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
    Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.
    Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
    Cancer Causes Control; 2008 Feb; 19(1):25-31. PubMed ID: 17906959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
    van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
    BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
    Hammarsten J; Högstedt B
    Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.